Colistin losing effectiveness against Pseudomonas superbug

Scientists found colistin is losing effectiveness against the hospital superbug Pseudomonas aeruginosa.

A key resistance gene in Pseudomonas mutates rapidly, rendering colistin less effective.

Colistin is considered the last-resort antibiotic for this superbug.

The rapid mutation of the resistance gene poses a significant challenge to treatment.